06:04 EDT Unicycive Therapeutics files to sell 111.02M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on UNCY:
- Unicycive Therapeutics price target lowered to $4 from $6 at Maxim
- Unicycive selloff brings ‘excellent entry point,’ says H.C. Wainwright
- Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program
- Unicycive Therapeutics provides NDA update based on recent FDA interactions
- Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET